GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression

Journal of Experimental Medicine

Volumn 196, Issue 11, 2002, Pages 1447-1459

  Baker LePain, Julie C ^a   Sarzotti, Marcella ^a   Fields, Timothy A ^a   Li, Chuan Yuan ^a   Nicchitta, Christopher V ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer; Chaperone; Dendritic cell; Heat shock protein; Immunotherapy

Indexed keywords

CD86 ANTIGEN; GELDANAMYCIN; GLYCOPROTEIN GP 96; IMMUNOLOGICAL ADJUVANT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CANCER MODEL; CELL CULTURE; CELL SECRETION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FIBROBLAST; IMMUNITY; IRRADIATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN SECRETION; TUMOR GROWTH; UPREGULATION; VACCINATION;

3T3 CELLS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; ANTIGENS, NEOPLASM; BENZOQUINONES; BINDING SITES; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; KILLER CELLS, NATURAL; LACTAMS, MACROCYCLIC; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; QUINONES; VACCINATION;

EID: 0037011072     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020436     Document Type: Article

References (59)

1. Srivastava, P.K. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20:395-425.
2. Srivastava, P.K., A.B. DeLeo, and L.J. Old. 1986. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA. 83:3407-3411.
3. Blachere, N.E., H. Udono, S. Janetzki, Z. Li, and P.K. Srivastava. 1993. Heat shock protein vaccines against cancer. J. Immunother. 14:352-356.
4. Tamura, Y., P. Peng, K. Liu, M. Daou, and P.K. Srivastava. 1997. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science. 278:117-120.
5. Srivastava, P.K., and M. Heike. 1991. Stress-induced proteins in immune response to cancer. Curr. Top. Microbiol. Immunol. 167:109-123.
6. Spee, P., and J. Neefjes. 1997. TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase, and calreticulin. Eur. J. Immunol. 27:1685-1690.
7. Singh-Jasuja, H., R.E.M. Toes, P. Spee, C. Munz, N. Hilf, S.P. Schoenberger, P. Riccardi-Castagnoli, J. Neefjes, H.G. Rammensee, D. Arnold-Schild, et al. 2000. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J. Exp. Med. 191:1965-1974.
8. Wassenberg, J.J., C. Dezfulizan, and C.V. Nicchitta. 1999. Receptor mediated and fluid phase pathways for internalization of the ER hsp90 chaperone GRP94 in murine macrophages. J. Cell Sci. 112:2167-2175.
9. Arnold-Schild, D., D. Hanau, D. Spehner, C. Schmid, H.G. Rammensee, H. de la Salle, and H. Schild. 1999. Cutting edge: Receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J. Immunol. 162:3757-3760.
10. Binder, R.J., D.K. Han, and P.K. Srivastava. 2000. CD91: A receptor for heat shock protein gp96. Nat. Immunol. 2:151-155.
11. Castellino, F., P.E. Boucher, K. Eichelberg, M. Mayhew, J.E. Rothman, A.N. Houghton, and R.N. Germain. 2000. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 191:1957-1964.
12. Suto, R., and P.K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1585-1588.
13. Berwin, B., M.F.N. Rosser, K.G. Brinker, and C.V. Nicchitta. 2002. Transfer of GRP94(gp96)-associated peptides onto endosomal MHC Class I molecules. Traffic. 3:358-366.
14. Singh-Jasuja, H., H.U. Scherer, N. Hilf, D. Arnold-Schild, H.G. Rammensee, R.E. Toes, and H. Schild. 2000. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30:2211-2215.
15. Basu, S., R.J. Binder, R. Suto, K.M. Anderson, and P.K. Srivastava. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12:1539-1546.
16. Asea, A., S.K. Kraeft, E.A. Kurt-Jones, M.A. Stevenson, L.B. Chen, R.W. Finberg, G.C. Koo, and S.K. Calderwood. 2000. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6:435-442.
17. Todryk, S., A. Melchner, N. Hardwock, E. Linardakis, A. Bateman, M. Colombo, A. Stoppacciaro, and R. Vile. 1999. Heat shock protein 70 induced during tumor killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 163:1398-1408.
18. Kol, A., A.H. Lichtman, R.W. Finberg, P. Libby, and E.A. Kurt-Jones. 2000. Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol. 164:13-17.
19. Ohashi, K., V. Burkart, S. Flohe, and H. Kolb. 2000. Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor 4-complex. J. Immunol. 164:558-561.
20. Janeway, C.A., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
21. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. 726 pp.
22. Haynes, R.L., T. Zheng, and C.V. Nicchitta. 1997. Structure and folding of nascent polypeptide chains during protein translocation in the endoplasmic reticulum. J. Biol. Chem. 272:17126-17133.
23. Wearsch, P.A., and C.V. Nicchitta. 1996. Purification and partial molecular characterization of GRP94, an ER resident chaperone. Protein Expr. Purif. 7:114-121.
24. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R.M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
25. Kornberg, A. 1990. Why purify enzymes? Methods Enzymol. 182:1-5.
26. Reed, R.C., T. Zheng, and C.V. Nicchitta. 2002. GRP94-associated enzymatic activities: Resolution by chromatographic fractionation. J. Biol. Chem. 277:25082-25089.
27. Baker-LePain, J.C., R.C. Reed, and C.V. Nicchitta. 2002. ISO: A critical evaluation of the role of peptides in heat shock/chaperone protein-mediated tumor rejection. Curr. Opin. Immunol. In press.
28. Munro, S., and H.R.B. Pelham. 1987. A C-terminal signal prevents secretion of lumenal ER proteins. Cell. 48:899-907.
29. Peter, F., V.P. Nguyen, and H.D. Soling. 1992. Different sorting of Lys-Asp-Glu-Leu proteins in rat liver. J. Biol. Chem. 267:10631-10637.
30. Aslakson, C.J., and F.R. Miller. 1992. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse marnmary tumor. Cancer Res. 52:1399-1405.
31. Wearsch, P.A., and C.V. Nicchitta. 1996. Endoplasmic reticulum chaperone GRP94 subunit assembly is regulated through a defined oligomerization domain. Biochemistry. 35:16760-16769.
32. Rosser, M.F.N., and C.V. Nicchitta. 2000. Ligand interactions in the adenosine nucleotide binding domain of the hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding. J. Biol. Chem. 275:22806-22814.
33. Prodromou, C., S.M. Roe, R. Obrien, J.E. Ladbury, P.W. Piper, and L.H. Pearl. 1997. Identification and structural characterization of the N-terminal domain of the ATP/ADP-binding site in the hsp90 molecular chaperone. Cell. 90:65-75.
34. Stebbins, C.E., A.A. Russo, N. Rosen, F.U. Hartl, and N.P. Pavletich. 1997. Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an anti-tumor agent. Cell. 89:239-250.
35. Linderoth, N.A., A. Popowicz, and S. Sastry. 2000. Identification of the peptide-binding site in the heat shock chaperone/tumor rejection antigen gp96 (Grp94). J. Biol. Chem. 275:5472-5477.
36. More, S., M. Breloer, B. Fleischer, and A. von Bonin. 1999. Activation of cytotoxic T cells in vitro by recombinant gp96 fusion proteins irrespective of the "fused" antigenic peptide sequence. Immunol. Lett. 69:275-282.
37. Breloer, M., B. Fleischer, and A. von Bonin. 1999. In vivo and in vitro activation of T cells after administration of Agnegative heat shock proteins. J. Immunol. 162:3141-3147.
38. Robert, J., J. Gantress, L. Rau, A. Bell, and N. Cohen. 2002. Minor histocompatibility antigen-specific MHC-restricted CD8 T cell responses elicited by heat shock proteins. J. Immunol. 168:1697-1703.
39. Zhu, X., X. Zhao, W.F. Burkholder, A. Gragerov, C.M. Ogata, M.E. Gottesman, and W.A. Hendrickson. 1996. Structural analysis of substrate binding by the molecular chaperone DnaK. Science. 272:1606-1614.
40. More, S.H., M. Breloer, and A. von Bonin. 2001. Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses: Hsp60-mediated activation of cytotoxic T cells. Int. Immunol. 13:1121-1127.
41. Asea, A., E. Kabingu, M.A. Stevenson, and S.K. Calderwood. 2000. HSP70 peptide-bearing and peptide-negative preparations act as chaperokines. Cell Stress Chaperones. 5:425-431.
42. + T cell independent. J. Exp. Med. 191:403-408.
43. Randow, F., and B. Seed. 2001. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat. Cell Biol. 3:891-896.
44. Ramunas, M.V., S. Braedel, N. Hilf, H. Singh-Jasuja, S. Herter, P. Ahmad-Nejad, C.J. Kirschning, C. da Costa, H. Rammensee, H. Wagner, et al. 2002. The endoplasmic reticulum-resident heat shock protein gp96 activtes dendritic cells via the toll-like receptor 2/4 pathway. J. Biol. Chem. 277:20847-20853.
45. Talmadge, J.E., K.M. Meyers, D.J. Prieur, and J.R. Starkey. 1980. Role of NK cells in tumor growth and metastasis in beige mice. Nature. 284:622-624.
46. Crowe, N.Y., M.J. Smyth, and D.I. Godfrey. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196:119-127.
47. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623-1626.
48. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol. 165:2665-2670.
49. Toura, I., T. Kawano, Y. Akutsu, T. Nakayama, T. Ochiai, and M. Taniguchi. 1999. Cutting edge: Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol. 163:2387-2391.
50. Zitvogel, L. 2002. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 195:F9-F14.
51. Fernandez, N.C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Sutter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: A cross-talk relevant in innate antitumor immune responses in vivo. Nat. Med. 5:405-411.
52. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R.C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90:3539-3543.
53. Marincola, F.M., S. Ettinghausen, P.A. Cohen, L.B. Cheshire, N.P. Restifo, J.J. Mule, and S.A. Rosenberg. 1994. Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha. J. Immunol. 152:3500-3513.
54. Chen, L., S. Ashe, W.A. Brady, I. Hellstrom, K.E. Hellstrom, J.A. Ledbetter, P. McGowan, and P.S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1093-1102.
55. + T cells by B7-transfected melanoma cells. Science. 259:368-370.
56. Hui, K., F. Gosveld, and H. Festenstein. 1984. Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation. Nature. 311:750-752.
57. Tanaka, K., E. Gorelik, M. Watanabe, N. Hozumi, and G. Jay. 1988. Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene. Mol. Cell. Biol. 8:1857-1861.
58. Yamazaki, K., T. Nguyen, and E.R. Podack. 1999. Cutting edge: Tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J. Immunol. 163:5178-5182.
59. Zheng, H., J. Dai, D. Stoilova, and Z. Li. 2001. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J. Immunol. 167:6731-6735.